Alumis Inc’s filing revealed that its Director Tananbaum James B. acquired Company’s shares for reported $0.12 million on May 02 ’25. In the deal valued at $4.62 per share,25,000 shares were bought. As a result of this transaction, Tananbaum James B. now holds 4,227,670 shares worth roughly $17.76 million.
Then, Tananbaum James B. bought 20,000 shares, generating $86,800 in total proceeds. Upon buying the shares at $4.34, the Director now owns 4,247,670 shares.
Before that, Foresite Labs, LLC bought 25,000 shares. Alumis Inc shares valued at $115,500 were divested by the 10% Owner at a price of $4.62 per share. As a result of the transaction, Foresite Labs, LLC now holds 4,227,670 shares, worth roughly $17.76 million.
Wells Fargo initiated its Alumis Inc [ALMS] rating to an Overweight in a research note published on July 25, 2025; the price target was $17. Oppenheimer began covering ALMS with “an Outperform” recommendation on January 30, 2025. Robert W. Baird started covering the stock on October 31, 2024. It rated ALMS as “an Outperform”.
Price Performance Review of ALMS
On Tuesday, Alumis Inc [NASDAQ:ALMS] saw its stock jump 2.69% to $4.2. Over the last five days, the stock has gained 6.33%. Alumis Inc shares have fallen nearly -66.90% since the year began. Nevertheless, the stocks have fallen -46.56% over the past one year.
How much short interest is there in Alumis Inc?
A steep rise in short interest was recorded in Alumis Inc stocks on 2025-07-15, growing by 8887.0 shares to a total of 3.23 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 3.22 million shares. There was a rise of 0.28%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 17, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $30 price target.
